The endoplasmic reticulum is the cellular factory where newly made proteins are folded, modified, and quality-checked before they move on to their final destinations. Because protein folding is chemically demanding and exquisitely sensitive to the cellular environment, the ER is among the first organelles to falter when a cell is under oxidative assault. When misfolded proteins accumulate, the ER activates a rescue program known as the unfolded protein response, orchestrated by sensor proteins including PERK, IRE1α, and ATF6, together with the chaperone GRP78. If the stress is mild, this response restores balance. If it is prolonged or severe, the response turns lethal, ramping up the transcription factor ATF4 and its downstream partner CHOP, a protein that pushes stressed cells toward apoptosis.

Nicotine, the addictive alkaloid in tobacco, is a potent pro-oxidant that generates reactive oxygen species and depletes cellular antioxidant defenses. Earlier studies had implicated nicotine in testicular damage, showing reduced gametogenesis, altered steroidogenesis, and increased apoptosis in animal models, and had even linked nicotine exposure to ER stress in tissues such as the placenta and airway smooth muscle. What remained unclear was whether the ER stress pathway was a genuine mechanistic driver of nicotine-induced sperm dysfunction in the testis, and whether antioxidants could intervene at that specific signaling node rather than merely mopping up free radicals.

To answer these questions, the researchers worked with 48 two-month-old male Wistar albino rats, dividing them into six experimental groups: an untreated control, a nicotine-exposed group, three groups receiving nicotine together with melatonin, coenzyme Q10, or both compounds, and a group receiving the two antioxidants without nicotine. The design allowed the team to disentangle the toxic effects of nicotine from the protective effects of each supplement, and to test whether the combination offered any advantage over either compound alone. Sperm quality was assessed using standard andrological measures, while testicular tissue was examined for oxidative stress markers, ER stress gene expression, histopathology, and the immunohistochemical localization of key stress proteins.

The results were striking. Nicotine exposure significantly impaired sperm motility and membrane integrity while increasing abnormal sperm morphology, sperm mortality, and apoptosis, with all of these changes reaching high statistical significance. Biochemically, the nicotine-exposed testes showed elevated lipid peroxidation, a hallmark of oxidative damage to cellular membranes, alongside a collapse of antioxidant defenses, including reduced levels of glutathione, glutathione peroxidase, and catalase. In other words, nicotine created a double hit: it flooded the tissue with reactive oxygen species while simultaneously stripping away the enzymes and molecules that would normally neutralize them.

The critical new finding concerned the ER. In the nicotine group, the expression of a battery of ER stress-associated genes was markedly upregulated, including ATF4, ATF6, CHOP, GRP78, IRE1α, and PERK, the full cast of the canonical unfolded protein response. Immunohistochemistry confirmed increased CHOP immunoreactivity in the tissue, indicating that the pro-apoptotic arm of the ER stress response was not merely transcribed but translated into accumulated protein. This pattern suggests that nicotine pushes testicular cells past the adaptive phase of ER stress and into the maladaptive, death-signaling phase, providing a mechanistic bridge between oxidative damage and the observed sperm apoptosis.

Antioxidant treatment changed the picture substantially. Melatonin, the pineal hormone best known for regulating circadian rhythm but also a versatile direct and indirect antioxidant, and coenzyme Q10, an essential component of the mitochondrial electron transport chain and a lipid-soluble radical scavenger, each partially restored sperm quality and antioxidant capacity when given alongside nicotine. At the molecular level, the supplements significantly downregulated the ER stress gene panel, tamping down the expression of ATF4, ATF6, CHOP, GRP78, IRE1α, and PERK, and reducing CHOP immunoreactivity in the tissue. Histopathological analysis showed corresponding protection of testicular architecture, preserving the seminiferous environment in which sperm develop.

One detail of the data may prove particularly interesting to researchers. Coenzyme Q10 selectively enhanced XBP-1 immunoreactivity, a marker associated with the IRE1α branch of the unfolded protein response. Because the IRE1α–XBP-1 arm is generally considered adaptive, promoting protein folding capacity and cellular survival rather than death, this selective effect hints that coenzyme Q10 may not simply suppress ER stress wholesale but may help re-balance the response toward its protective branch. Melatonin, meanwhile, has previously been shown to modulate ER stress in contexts ranging from arsenite-induced neurotoxicity to fulminant hepatitis and testicular injury from bisphenol A and phthalates, and the new findings extend that mechanistic portfolio to nicotine-driven reproductive damage.

The authors are careful about scope. This is a rat study, with controlled dosing and a defined exposure window, and the leap from rodent testes to human male fertility is neither automatic nor trivial. The supplements produced partial rather than complete protection, which itself is informative: nicotine inflicts damage through multiple converging pathways, including vascular effects, hormonal disruption, and direct genotoxicity, so no single antioxidant can be expected to erase the harm. Data from the study are available upon reasonable request, and the work was supported by the Scientific Research Projects Coordination Unit of Hatay Mustafa Kemal University, with ethics approval from the institution’s Local Animal Ethics Committee.

Even with those caveats, the study carries real weight for a public health conversation that often treats smoking-related fertility damage as an afterthought. It identifies a specific, druggable signaling axis, the oxidative stress–ER stress–CHOP cascade, as a mediator of nicotine’s assault on sperm, and it demonstrates that two inexpensive, widely available compounds can intervene at that axis in a living animal. For the millions of smokers whose fertility may be quietly eroding, the message is not that a supplement can undo the damage of smoking, but that the biology of that damage is now understood well enough to be targeted, and that the surest intervention remains removing the toxin itself. Translational studies in human populations will be needed before melatonin or coenzyme Q10 can be recommended clinically, but as a proof of mechanism, this work sharpens the picture of how tobacco smoke reaches deep into the cellular machinery of reproduction.

Subject of Research: Nicotine-induced oxidative stress and endoplasmic reticulum stress signaling in rat testis and its attenuation by melatonin and coenzyme Q10

Article Title: Targeting the Nicotine-driven Maladaptive ER Stress Axis: Protective Roles of Melatonin and Coenzyme Q10 in Rat Testis

Article References: Eraslan Sakar, A., Yildiz, C., Coskun, N., Sengul, S. A., Akcakavak, F. K., Kutlu, T., Sayan, M., & Karabulut, D. (2026). Targeting the Nicotine-driven Maladaptive ER Stress Axis: Protective Roles of Melatonin and Coenzyme Q10 in Rat Testis. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02235-z

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02235-z

Keywords: nicotine, endoplasmic reticulum stress, melatonin, coenzyme Q10, sperm quality, male fertility, oxidative stress, testis, apoptosis, unfolded protein response, CHOP, rat model

The review team, led by Deborah Doyin Alade of Elizade University in Nigeria together with colleagues at Kampala International University and Redeemer’s University, conducted a systematic literature search on January 15, 2026, across PubMed, Scopus, Web of Science, and Google Scholar. Their search terms captured cadmium alongside male reproductive system, testicular toxicity, spermatogenesis, and sperm quality. From the resulting pool, twenty studies met the inclusion criteria: five human observational studies and fifteen animal studies, fourteen of which were controlled experiments and one of which was an environmental field study. Because the studies varied enormously in design, exposure levels, duration, models, and outcome measures, the authors synthesized the data narratively rather than statistically, a choice that reflects the messy reality of toxicology across species and dose ranges.

Cadmium enters the body primarily through contaminated food, cigarette smoke, and occupational settings such as battery manufacturing, welding, and metal smelting. What makes the metal particularly insidious is its biological half-life, which can span decades in human tissue. The kidney and liver accumulate the largest burdens, but the testis is remarkably vulnerable because it lacks the robust metal-detoxifying capacity of other organs. The review emphasizes that cadmium mimics essential divalent metals such as zinc and calcium, allowing it to slip through transport channels designed for nutrients. Once inside the testis, it attacks the very structures that make sperm production possible, and it does so through several parallel mechanisms that the included studies dissected in detail.

One of the most extensively documented targets is the blood-testis barrier, a specialized junctional complex formed by Sertoli cells that shields developing germ cells from the immune system and from circulating toxins. Cadmium disrupts the tight junction proteins that hold this barrier together, causing it to become leaky. When the barrier fails, germ cells lose their protected environment, immune components can infiltrate the seminiferous tubules, and the precisely choreographed process of spermatogenesis breaks down. Animal studies in the review documented structural alterations to the seminiferous epithelium, damage to both Sertoli cells, which nurse developing sperm, and Leydig cells, which produce testosterone, and a general disorganization of testicular architecture that correlates with falling sperm counts.

The molecular engine behind much of this damage is oxidative stress. Cadmium does not directly generate reactive oxygen species the way some toxins do; instead, it cripples the cell’s antioxidant defenses, depleting glutathione and suppressing the activity of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. The resulting imbalance allows reactive oxygen species to accumulate unchecked, attacking lipids in sperm membranes, fragmenting DNA, and oxidizing proteins essential for motility. Sperm are particularly defenseless because their cytoplasm is minimal, leaving them with limited repair machinery. Several animal studies in the review measured elevated markers of lipid peroxidation alongside reduced antioxidant capacity, painting a consistent picture of redox collapse in exposed testicular tissue.

Beyond oxidative damage, the review catalogued a second lethal pathway: apoptosis, or programmed cell death. Cadmium exposure triggered the activation of caspase enzymes and shifts in the balance of Bcl-2 family proteins, tipping germ cells toward self-destruction. Mitochondrial dysfunction appears to be a central node connecting the oxidative and apoptotic cascades, since damaged mitochondria both leak reactive oxygen species and release cytochrome c, a key initiator of the apoptotic program. The studies also reported alterations in metallothionein expression, the cell’s attempt to sequester the metal, and broader molecular perturbations affecting DNA integrity. Together, these mechanisms explain how relatively low-level, chronic exposure can progressively erode sperm output without causing outright tissue necrosis.

Hormonal disruption adds another layer of complexity. The hypothalamic-pituitary-gonadal axis, which coordinates reproductive function through the pulsatile release of gonadotropin-releasing hormone, follicle-stimulating hormone, and luteinizing hormone, is sensitive to cadmium’s interference at multiple points. Studies included in the review reported changes in testosterone, FSH, and LH levels following exposure, consistent with direct toxicity to Leydig cells and indirect feedback effects from damaged seminiferous tubules. Because sperm production depends on both local testosterone concentrations within the testis and the central hormonal command system, cadmium’s dual action on the axis and on the gonads compounds its impact on fertility.

The five human observational studies generally supported the associations seen in animals, linking cadmium exposure to adverse sperm parameters and oxidative stress markers in men. However, the review is careful to note that the human evidence is not entirely consistent, and several of the studies involved potential confounding or co-exposure to other toxicants such as lead and arsenic, making it difficult to attribute observed reproductive outcomes specifically to cadmium. This is a familiar challenge in environmental epidemiology: people are rarely exposed to a single pollutant in isolation, and lifestyle factors such as smoking, which itself delivers cadmium, further complicate the picture. The authors conclude that while the human data point in the same direction as the animal work, they fall short of establishing causation on their own.

On the question of protection, the animal literature offers some grounds for cautious optimism. The review found that antioxidant supplementation, zinc administration, and various plant-derived interventions appeared to attenuate selected cadmium-associated reproductive effects in experimental models. Zinc is mechanistically plausible, since cadmium competes with zinc for binding sites and uptake pathways, and adequate zinc status may partially crowd out the toxicant. Antioxidant compounds can theoretically restore the redox balance that cadmium destroys. But the authors are emphatic that evidence for the effectiveness of these interventions in humans is limited, and no included study provided the kind of rigorous clinical trial data that would justify recommending supplements as a shield against cadmium exposure. The most reliable protection, they suggest, remains reducing exposure itself.

The review’s conclusions carry clear public health implications. Cadmium contamination of soil and food crops, particularly rice and leafy vegetables grown in polluted regions, continues in many parts of the world, and occupational exposure remains a reality for workers in metallurgy, plastics, and battery recycling. The authors call for longitudinal human studies with standardized exposure assessment, careful control of confounding factors, and deeper investigation of molecular and epigenetic mechanisms, noting that the current evidence base is dominated by animal work with heterogeneous designs. They also urge stronger efforts to reduce occupational and environmental cadmium exposure and to improve exposure monitoring. For now, the message from six years of accumulated research is that a metal most people have never thought about may be quietly working against male reproductive health, and that the scientific case for taking it seriously has never been stronger.

Subject of Research: Effects of cadmium exposure on male reproductive health, including testicular toxicity, spermatogenesis, sperm quality, and underlying molecular mechanisms

Article Title: Cadmium exposure and male reproductive health: a systematic review of mechanisms and reproductive outcomes (2020–2026)

Article References: Alade, D. D., Arogundade, A. B., Ismahil, A. A., Shehu, U. U., Ikuomola, E. O., & Abodunrin, V. K. (2026). Cadmium exposure and male reproductive health: a systematic review of mechanisms and reproductive outcomes (2020–2026). BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01248-3

Image Credits: AI Generated

DOI: 10.1186/s40360-026-01248-3

Keywords: cadmium, male reproductive health, testicular toxicity, spermatogenesis, sperm quality, oxidative stress, apoptosis, blood-testis barrier, reproductive hormones, heavy metal toxicity, environmental health, systematic review

The research team, working at Islamic Azad University’s Central Tehran Branch in collaboration with Shahid Beheshti University, set out to fill a conspicuous gap in the literature. Although Lactobacillus strains have long been associated with protective effects in the female genitourinary tract, their potential to safeguard male reproductive health under active bacterial challenge had never been rigorously tested in a controlled experimental model. The investigators designed a study using a native Iranian probiotic and postbiotic formulation containing three strains: Lactobacillus casei, Lactobacillus rhamnosus, and Lactobacillus helveticus. Their goal was to assess whether these interventions could protect renal integrity, testicular function, and sperm quality in rats experimentally infected with E. coli.

The experimental design was straightforward but comprehensive. Twenty-eight adult male Wistar rats, each weighing between 200 and 250 grams, were acclimatized for one week under controlled conditions of a 12-hour light-dark cycle and an ambient temperature of 23 degrees Celsius. The animals were then divided into four groups: an uninfected control group, a group infected orally with E. coli at a concentration of 10 to the eighth colony-forming units per millilitre for three consecutive days, and two infected groups that subsequently received either the probiotic mixture or the postbiotic preparation by daily oral gavage for 35 days. The postbiotic was prepared by culturing the probiotic powder, centrifuging the suspension, and filtering it through a 0.22-micrometre membrane to obtain cell-free metabolites, ensuring that no living bacteria remained in that treatment arm.

The results were striking. Histopathological examination of kidney tissue revealed that infected rats suffered severe damage, including vacuolar degeneration of tubular cells, extensive haemorrhage, collagen fibre deposition, cellular necrosis, and dense lymphocyte infiltration. Periodic acid–Schiff staining, which highlights basement membrane integrity, confirmed the extent of the injury. In contrast, rats treated with either probiotics or postbiotics showed markedly attenuated pathology, with reduced vacuolization, diminished inflammatory infiltration, and improved glomerular structure. Three blinded pathologists independently scored the sections, achieving an inter-observer agreement coefficient of 0.82, which lends considerable statistical weight to the visual findings.

The testes told a parallel story. Infection caused a significant drop in testicular weight and volume, shrank the diameter of seminiferous tubules from roughly 243 micrometres in controls to 173 micrometres in infected animals, and thinned the germinal epithelium that houses developing sperm cells. The lumen of the tubules, meanwhile, expanded abnormally, a hallmark of germ cell loss. Probiotic and postbiotic supplementation partially reversed these changes: tubule diameter recovered to around 212 to 214 micrometres, germ cell layer thickness rebounded from 149 to roughly 244 to 250 micrometres, and testicular weight climbed back toward control values. Sperm analysis reinforced the pattern, with infected rats showing reduced sperm counts, impaired viability, and abnormal morphology, all of which improved modestly with either treatment.

Blood chemistry provided further evidence of renal protection. Serum urea and creatinine, two classic markers of kidney dysfunction, rose sharply in infected rats compared with controls. Treatment with probiotics or postbiotics significantly lowered both markers relative to the infected group, with creatinine reductions reaching statistical significance at the p less than 0.01 level. Serum potassium followed a similar trend, while sodium concentrations remained unchanged across all groups, indicating that the interventions did not disturb electrolyte homeostasis. These biochemical improvements aligned closely with the histological recovery observed under the microscope.

At the molecular level, the researchers used real-time polymerase chain reaction to quantify the expression of genes governing apoptosis and inflammation. Infection drove a significant upregulation of Bax, a pro-apoptotic gene, alongside elevated expression of the inflammatory cytokines tumour necrosis factor-alpha and interleukin-6 in both kidney and testicular tissue. The anti-apoptotic gene Bcl-2, by contrast, was suppressed. Probiotic and postbiotic treatment flipped this profile: Bax, TNF-alpha, and IL-6 expression fell dramatically compared with infected animals, while Bcl-2 rose significantly. The authors interpret this dual modulation of apoptotic and inflammatory pathways as the central mechanism by which the interventions preserved tissue integrity.

Antioxidant capacity emerged as another critical piece of the puzzle. Total antioxidant capacity in both kidney and testicular tissue was significantly depleted by infection, reflecting the oxidative stress that bacterial pathogens impose on host cells. Supplementation restored these values substantially, with postbiotic-treated animals even showing a modest, though not statistically significant, increase above control levels in kidney tissue. This restorative effect on antioxidant defences likely complements the anti-inflammatory and anti-apoptotic actions, since reactive oxygen species and inflammatory signalling reinforce one another in a vicious cycle that probiotic metabolites appear able to interrupt.

The mechanisms behind these effects are consistent with a growing body of microbiome research. Lactobacillus strains produce lactic acid, hydrogen peroxide, and bacteriocins that directly inhibit pathogenic colonization, while reinforcing epithelial barrier function and modulating toll-like receptor signalling, dendritic cell activity, and cytokine production. Postbiotics, comprising proteins, lipids, short-chain fatty acids, and other fermentation products, deliver many of these benefits without the logistical and safety concerns associated with live microorganisms, which is particularly relevant for immunocompromised patients. The multi-strain approach used here may also amplify protection, as prior studies suggest that combining strains with diverse metabolic and immunomodulatory properties produces synergistic effects.

The authors are careful to note that recovery was partial rather than complete, and that the study was conducted in a rodent model with a defined bacterial challenge rather than the complex, recurrent infections seen in clinical practice. Dose optimization, strain selection, timing of administration, and long-term safety evaluation all remain open questions before such interventions can be recommended for human use. Nevertheless, the findings add meaningful weight to the argument that microbiota-based therapies could serve as adjuncts or alternatives to antibiotics at a moment when antimicrobial resistance is escalating globally. If the protective effects observed in these rats translate to humans, a simple mixture of Lactobacillus strains or their metabolites might one day help men preserve both kidney function and fertility in the face of one of medicine’s most persistent bacterial adversaries.

Subject of Research: Protective effects of Lactobacillus-derived probiotics and postbiotics on renal and reproductive function in E. coli-infected rats

Article Title: Protective Effects of Lactobacillus‐Derived Probiotics and Postbiotics on Renal and Reproductive Function in Escherichia coli–Infected Rats

Article References: Sedghi, S., Keshtmand, Z., & Hosseini, S. (2026). Protective Effects of Lactobacillus ‐Derived Probiotics and Postbiotics on Renal and Reproductive Function in Escherichia coli –Infected Rats. Veterinary Medicine and Science, 12(6), Article e71258. https://doi.org/10.1002/vms3.71258

Image Credits: AI Generated

DOI: 10.1002/vms3.71258

Keywords: probiotics, postbiotics, Lactobacillus, Escherichia coli, urinary tract infection, male infertility, kidney injury, testicular function, sperm quality, oxidative stress, apoptosis, antimicrobial resistance

The experimental design was deliberately rigorous. Forty male Sprague Dawley rats were divided into four groups: a control group on a standard diet, an obesity group, a Kisspeptin-10 group, and a group that was both obese and treated with the peptide. Obesity was induced by feeding the animals a high-fat diet in which 60 percent of calories came from fat for twelve weeks, a demanding regimen designed to mimic the metabolic burden of chronic dietary excess in humans. At the end of that period, rats with a Lee index of 300 or above, a standard anthropometric measure of adiposity in rodents, were classified as obese. Treatment then ran for a further four weeks, during which the obese groups continued on the high-fat diet while Kisspeptin-10 was administered intraperitoneally at a dose of 50 nanomoles per kilogram to the two designated groups.

The damage that obesity inflicted on the reproductive system was clear and multifaceted. In the untreated obese rats, the researchers measured a decline in antioxidant capacity within the testes, alongside an increase in malondialdehyde, or MDA, a well-established marker of lipid peroxidation. Lipid peroxidation is essentially the oxidative degradation of the fatty membranes that surround cells and organelles, and spermatozoa are particularly vulnerable because their membranes are unusually rich in polyunsaturated fatty acids. When those membranes are attacked by reactive oxygen species, sperm motility, membrane integrity, and fertilizing capacity all suffer. The obese animals also showed reduced sperm concentration and motility, a higher proportion of sperm with tail abnormalities, impaired mitochondrial function, reduced reproductive organ weights, and evidence of sperm DNA damage.

Against that bleak backdrop, the effects of Kisspeptin-10 were striking in several domains. Treated animals showed significantly lower MDA levels and higher levels of glutathione, or GSH, one of the cell’s most important endogenous antioxidants. Glutathione acts as the cell’s primary redox buffer, neutralizing peroxides and detoxifying electrophilic compounds through conjugation reactions, so its restoration signals a meaningful rebalancing of the testicular redox environment. The peptide also improved sperm motility and concentration, reduced the ratio of tail-abnormal sperm, and decreased sperm DNA damage. Additionally, the researchers observed an increase in prostate weight in treated animals, suggesting a broader trophic effect on the male reproductive tract.

Perhaps the most intriguing part of the study concerned mitochondria, the energy-producing organelles that sperm depend on almost entirely for the power needed to swim. Sperm mitochondria sit in the midpiece of the cell and generate the ATP that drives flagellar beating, and their membrane potential, known as MMP, is a widely used proxy for mitochondrial health. In the present study, obesity impaired sperm MMP, and while Kisspeptin-10 treatment showed only a non-significant tendency toward partial restoration of mitochondrial function, the molecular data hinted at a deeper story. The researchers measured the expression of proteins involved in mitophagy, the specialized form of autophagy that selectively identifies and removes damaged mitochondria before they can leak reactive oxygen species and trigger cell death.

That story centered on two proteins in particular. PTEN-induced putative kinase 1, or PINK1, accumulates on the surface of damaged mitochondria and recruits the ubiquitin ligase Parkin to tag those organelles for degradation. Prohibitin 2, or PHB2, is an inner mitochondrial membrane protein that serves as a receptor for the autophagy machinery, linking damaged mitochondria to the engulfing autophagosome. In the Kisspeptin-10-treated rats, expression of both PINK1 and PHB2 was increased, suggesting that the peptide may enhance the cell’s ability to recognize and clear dysfunctional mitochondria. The researchers also observed increased expression of Beclin-1, a core component of the class III phosphatidylinositol 3-kinase complex that initiates autophagosome formation, indicating broader engagement of the autophagy pathway.

Not every measured parameter responded, and the authors are candid about those limits. Expression of Parkin itself, the downstream ubiquitin ligase in the canonical PINK1-Parkin pathway, did not change significantly, nor did LC3-II, the lipidated form of the microtubule-associated protein light chain 3 that marks mature autophagosomes. Apoptosis-related proteins were likewise unaffected. This pattern suggests that Kisspeptin-10’s influence on mitochondrial quality control may operate primarily at the level of damage recognition and initiation rather than at the downstream execution steps of autophagic degradation or programmed cell death. Whether longer treatment durations, higher doses, or different disease models would recruit those downstream arms of the pathway remains an open question for future work.

The biological plausibility of these effects rests on kisspeptin’s expanding résumé. Encoded by the KiSS-1 gene and acting through the GPR54 receptor, kisspeptin is the critical upstream regulator of gonadotropin-releasing hormone neurons, and its administration potently stimulates luteinizing hormone release in both men and women. But a growing body of evidence suggests the peptide has direct protective actions in peripheral tissues as well. Previous studies have shown that Kisspeptin-10 ameliorates methotrexate-induced sperm damage and testicular oxidative stress in rats, reduces lipid peroxidation in testicular tissue, protects against amyloid-beta neurotoxicity in vitro, and improves testicular redox status in hypothyroid animals. The new findings extend that protective profile into the context of metabolic disease, where the interplay between obesity, leptin signaling, and reproductive function has long implicated kisspeptin as a potential mediator.

The clinical implications are considerable. Meta-analyses have consistently shown that elevated body mass index is associated with reduced sperm count and altered semen parameters in men, and obesity now affects hundreds of millions of adults worldwide. Because sperm mitochondrial membrane potential is a recognized predictor of sperm motility, and because mitochondrial dysfunction is increasingly recognized as a central mechanism linking metabolic disease to reproductive failure, interventions that restore mitochondrial quality control could address a root cause rather than a symptom. The authors suggest that Kisspeptin-10 may alleviate obesity-induced testicular dysfunction through modulation of redox balance and mitochondrial quality-control mechanisms, and they describe the peptide as a promising candidate for treating obesity-related male infertility, while acknowledging that its effects on downstream autophagy signaling and apoptosis appear limited.

As with all rodent studies, the path from a 50-nanomole-per-kilogram intraperitoneal injection in Sprague Dawley rats to a safe and effective human therapy will require careful translation. Dose optimization, route of administration, treatment duration, and safety profiling all remain to be established, and the non-significant mitochondrial membrane potential findings underscore that the functional benefits may lag behind the molecular signals. Still, the study offers a compelling proof of concept: a hormone that nature already placed at the top of the reproductive control hierarchy may also possess the cellular janitorial powers needed to keep sperm factories running cleanly under the chronic stress of obesity. For a field in which treatment options for obese men with impaired fertility remain limited largely to weight loss and antioxidant supplementation, that combination of endocrine authority and mitochondrial housekeeping makes kisspeptin a name worth watching closely.

Subject of Research: Effects of Kisspeptin-10 on obesity-induced testicular oxidative stress, sperm dysfunction, and mitochondrial quality control in rats

Article Title: Kisspeptin-10 Alleviates Obesity-induced Testicular Oxidative Stress and Mitochondrial Dysfunction via Modulation of Mitophagy and Autophagy Signaling

Article References: Arkalı, G., Çay, M., Güler Ekmen, E., Acısu, T. C., Fi̇ri̇k, M., Toz, A., Yüce, A., & Aksakal, M. (2026). Kisspeptin-10 Alleviates Obesity-induced Testicular Oxidative Stress and Mitochondrial Dysfunction via Modulation of Mitophagy and Autophagy Signaling. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02211-7

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02211-7

Keywords: Kisspeptin-10, obesity, male infertility, oxidative stress, mitophagy, autophagy, mitochondria, sperm quality, testis, PINK1, glutathione, reproductive sciences

Sertoli cells are the architectural and metabolic backbone of the seminiferous tubules, the coiled structures inside the testis where sperm are made. Each Sertoli cell extends from the basement membrane to the tubule lumen and physically cradles developing germ cells at every stage of their maturation, from spermatogonial stem cells through spermatocytes and spermatids to fully formed sperm. Beyond structural support, these cells supply nutrients, regulate the local hormonal environment, and maintain the polarity of the seminiferous epithelium. They also perform a housekeeping task that is easy to overlook: phagocytosing residual bodies, the excess cytoplasm discarded by spermatids as they transform into streamlined spermatozoa. Without this continuous clearance and recycling, the tubule becomes cluttered and germ cell development stalls.

A defining structure in this system is the blood-testis barrier, a constellation of tight junctions between adjacent Sertoli cells near the base of the tubule. The barrier partitions the seminiferous epithelium into basal and adluminal compartments, shielding meiotic and post-meiotic germ cells from the bloodstream and from the immune system, which would otherwise recognize haploid sperm antigens as foreign. The integrity of this barrier depends on junctional proteins such as Claudin-11, a claudin family member that is highly expressed in Sertoli cells and is required for normal barrier function. Disrupting the barrier does not merely expose germ cells to immune attack; it also destabilizes the polarized architecture that germ cells need to advance through the epithelium.

Beclin1, encoded by the Becn1 gene, is a core component of the autophagy initiation complex. Autophagy begins when a cup-shaped membrane, the phagophore, sequesters cytoplasmic cargo and seals into a double-membraned autophagosome, which then fuses with lysosomes for degradation. Beclin1 partners with the lipid kinase PIK3C3 (also known as VPS34) to nucleate this process, and its activity is modulated by interacting proteins such as Rubicon, which suppresses autophagic degradation, and ULK1, which initiates it. Because complete loss of Beclin1 is lethal early in embryonic development, researchers have had to rely on tissue-specific knockout strategies to probe its function in adult organs, and the testis has proven a particularly informative setting.

The Beijing team, led by Yuqing Cai and corresponding authors Yinghe Qin and Yingjie Wu, generated mice in which Becn1 was deleted only in Sertoli cells. The conditional knockout males were fertile in early adulthood, but their reproductive performance declined sharply. At nine weeks of age—the onset of full sexual maturity in the mouse—they sired fewer offspring and produced sperm of reduced quality. Histological examination of their testes revealed vacuolated seminiferous tubules, a hallmark of epithelial disorganization in which fluid-filled cavities disrupt the orderly layers of germ cells. By twelve weeks, the mice were completely infertile, indicating a progressive degeneration rather than a static developmental defect.

The cellular explanation for this collapse lay in two interlocking failures. First, the blood-testis barrier was compromised: the knockout testes showed disrupted barrier integrity and reduced expression of Claudin-11, the tight junction protein that helps seal the epithelium. Second, autophagy itself was clearly impaired. The researchers measured the ratio of LC3-II to LC3-I, a standard biochemical readout of autophagosome formation in which the soluble LC3-I protein is lipidated to membrane-bound LC3-II as autophagosomes assemble. In the absence of Beclin1, this ratio fell, demonstrating that Sertoli cells could no longer form autophagosomes efficiently. The autophagic flux that normally clears damaged organelles, protein aggregates and phagocytosed residual bodies had been throttled at its initiation step.

These results dovetail with a growing body of evidence that autophagy is not a generic housekeeping pathway in the testis but a process with specific, stage-specific reproductive duties. Previous work has shown that the autophagy protein ATG5 is required for the development of elongating spermatids, sperm individualization and normal male fertility, while Atg7 is essential for acrosome biogenesis, the construction of the enzyme-filled cap that sperm need to penetrate an egg. In Sertoli cells, autophagy has been implicated in the assembly of ectoplasmic specializations, the actin-based adhesive junctions that anchor spermatids, and in the regulation of cell polarity through PIK3C3’s control of the actin-severing protein scinderin. Conversely, the autophagy suppressor Rubicon promotes Sertoli cell function by preventing the degradation of the transcription factor GATA4, illustrating that the pathway must be tuned, not merely maximized.

What makes the new study notable is its focus on the initiation machinery rather than the downstream execution proteins. Earlier work from the same group had shown that Beclin1 is vital for spermatogenesis and male fertility when studied more broadly; the present study sharpens the picture by deleting the gene exclusively in Sertoli cells and tracing the resulting pathology to barrier disruption and failed autophagosome formation. This matters because Sertoli cell dysfunction is increasingly recognized as a contributor to unexplained male infertility in humans. While many cases of poor sperm quality are attributed to the germ cells themselves, the new data reinforce the idea that the somatic niche can be the primary fault line: when the nurse cells falter, the germ cells they support fail secondarily.

The study also connects autophagy to the metabolic economics of the tubule. Sertoli cells metabolize glucose into lactate, which they export to germ cells as a preferred fuel, and recent work in Tibetan sheep has shown that BECN1-mediated autophagy activates the glycolytic pathway that drives this lactate synthesis. A Sertoli cell stripped of Beclin1 may therefore be compromised not only in waste clearance and junction maintenance but also in metabolic provisioning, compounding the stress on developing germ cells. The vacuolation observed in the knockout tubules is consistent with such a multi-system failure, in which barrier breakdown, impaired phagocytosis and metabolic shortfall reinforce one another.

For now, the findings are confined to mice, and translating them to human fertility medicine will require caution. Yet they suggest concrete directions for research: screening for impaired autophagic flux in Sertoli cells of infertile men, exploring whether environmental factors known to perturb autophagy also affect barrier integrity, and investigating whether pharmacological modulation of the pathway could protect the niche. The work, supported by approved animal protocols at China Agricultural University and published as an open record with all data contained in the article, adds Beclin1 to the short list of genes whose deletion in Sertoli cells alone is sufficient to render a male mouse infertile. In the intricate economy of the seminiferous tubule, it appears the janitors are as indispensable as the workers they serve.

Subject of Research: The role of the autophagy protein Beclin1 in Sertoli cell function and mouse spermatogenesis

Article Title: Beclin1 Regulates Sertoli Cell Function to Maintain Mouse Spermatogenesis

Article References: Beclin1 Regulates Sertoli Cell Function to Maintain Mouse Spermatogenesis. (n.d.). https://doi.org/10.1007/s43032-026-02202-8

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02202-8

Keywords: autophagy, Beclin1, Sertoli cells, spermatogenesis, blood-testis barrier, male infertility, Claudin-11, LC3, knockout mice, sperm quality, seminiferous tubules, reproductive biology